Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

Conditions: Malignant Mesothelioma|Metastatic Cancer|Peritoneal Cavity Cancer
Start Date: October 1, 2001
Phase:
Status: Completed
NCT ID: NCT00028782
Study Type: Interventional
Intervention: Drug: EF5|Other: fluorescent antibody technique|Other: immunohistochemistry staining method
Study Design: Masking: Open Label|Primary Purpose: Diagnostic
Results: No Results Available
Sponsors: University of Pennsylvania|National Cancer Institute (NCI)
Ages: Adult|Senior
Enrollment: 80
Funded By: Other|NIH
First Received: January 4, 2002
End Date:
Last Updated: February 6, 2009
Last Verified: September 1, 2007

Mesothelioma
Lawsuit Evaluation

First Name
Last Name
Phone Number
Email
Zip Code
Details:
Please Include Diagnosis Date
Type The Number Below: